5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline
C22H29FN4O — CID 155418683
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline
5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline (PubChem CID 155418683) has the molecular formula C22H29FN4O and a molecular weight of 384.50 g/mol. Its IUPAC name is 5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline.
Molecular Properties
| Compound Name | 5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline |
|---|---|
| PubChem CID | 155418683 |
| Molecular Formula | C22H29FN4O |
| Molecular Weight | 384.50 g/mol |
| Exact Mass | 384.23 |
| IUPAC Name | 5-cyclobutyloxy-6-[1-(4-fluoropyrrolidin-3-yl)pyrazol-4-yl]-1,2-dimethyl-3,4-dihydro-2H-quinoline |
| SMILES | CC1CCc2c(ccc(-c3cnn(C4CNCC4F)c3)c2OC2CCC2)N1C |
| InChI | InChI=1S/C22H29FN4O/c1-14-6-7-18-20(26(14)2)9-8-17(22(18)28-16-4-3-5-16)15-10-25-27(13-15)21-12-24-11-19(21)23/h8-10,13-14,16,19,21,24H,3-7,11-12H2,1-2H3 |
| InChIKey | ZSQUVEYABHMZQV-UHFFFAOYSA-N |
| XLogP | 3.73 |
| TPSA | 42.32 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 384.50 |
| LogP ≤ 5 | 3.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155418683 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.